Integrative analysis of T cell-mediated tumor killing-related genes reveals KIF11 as a novel therapeutic target in esophageal squamous cell carcinoma
Abstract Background Immune checkpoint inhibitors (ICIs) are emerging promising agents for the treatment of patients with esophageal squamous cell carcinoma (ESCC), however, there are only a small proportion respond to ICI therapy. Therefore, selecting candidate patients who will benefit the most fro...
Saved in:
| Main Authors: | Xinxin Cheng, Huihui Zhao, Zhangwang Li, Liping Yan, Qingjie Min, Qingnan Wu, Qimin Zhan |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-02-01
|
| Series: | Journal of Translational Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12967-025-06178-y |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Construction of a novel copper-induced-cell-death-related gene signature for prognosis in colon cancer, with focus on KIF7
by: Hua Li, et al.
Published: (2024-12-01) -
Blocking SLC7A11 attenuates the proliferation of esophageal squamous cell carcinoma cells
by: Wen-Ting Li, et al.
Published: (2024-12-01) -
Unique Function in Cancer Stemness and Prognostic Significance of <i>EMX2</i> in Esophageal Squamous Cell Carcinoma
by: Shoichi Fumoto, et al.
Published: (2025-06-01) -
A prognostic nomogram that includes MPV in esophageal squamous cell carcinoma
by: Qiao He, et al.
Published: (2023-10-01) -
Microcephaly with or without chorioretinopathy, lymphedema, or mental retardation associated with KIF11 pathogenic variant: case report and genotype-phenotype correlation analysis
by: Jiajia Peng, et al.
Published: (2025-07-01)